Tuesday April 01, 2025
07:00-08:00
ON-DEMAND SYMPOSIA - ONLINE ONLY
On-Demand Oral Gallery
08:00-15:30
PRE CONFERENCE SYMPOSIUM
Hall A
PRE CONFERENCE SYMPOSIUM
Hall E
PRE CONFERENCE SYMPOSIUM
Hall B
15:45-16:35
OPENING CEREMONY AND AWARDS
Hall A
16:35-17:35
PLENARY LECTURE 01 & 02
Hall A
17:45-17:55
SHORT BREAK
Exhibition
17:45-18:30
FORUM 01: VARYING REGULATORY PHILOSOPHIES AND AD APPROVAL PRIORITIES - USA, EU, ASIA, AND OTHER PARTS OF THE WORLD
Hall A
18:30-19:15
FIRESIDE CHAT 03
Hall A
19:20-21:00
WELCOME RECEPTION IN EXHIBITION
Exhibition
Wednesday April 02, 2025
07:00-08:00
ON-DEMAND SYMPOSIA - ONLINE ONLY
On-Demand Oral Gallery
08:00-08:30
PLENARY LECTURE 03
Hall A
08:30-08:40
BREAK
Exhibition
08:40-10:40
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
DEMENTIA PREVENTION AND TREATMENT STRATEGIES; DIAGNOSIS AND STAGING OF AD
Hall E
APOE MECHANISMS AND TREATMENT STRATEGIES
Hall B
ABETA TOXICITY: OLIGOMERS, PLAQUES AND INTERACTION WITH TAU
Hall C
EXTRACELLULAR VESICLES AND BRAIN PATHOLOGY
Hall F1
GENETIC AND EPIDEMIOLOGICAL INSIGHTS IN AD & PD
Hall F2
10:40-11:10
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
11:10-12:50
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
12:50-13:50
EXHIBITION, POSTERS, LUNCH & INFORMAL NETWORKING WITH PROFESSORS
Exhibition
13:50-14:50
FORUM 02: INTEGRATING BLOOD-BASED, CSF AND IMAGING BIOMARKERS WITH DIGITAL TOOLS AND AI IN MCI & AD: HOW CLOSE ARE WE TO VALIDATION IN STANDARD OR PRECISION MEDICINE?
Hall A
TREM2, MICROGLIA: FROM MECHANISMS TO POTENTIAL TREATMENTS
Hall E
GENETICS OF NEURODEGENERATION: NEW FINDINGS AND ASSOCIATIONS
Hall B
ALPHA--SYNUCLEIN, AGGREGATION, MISFOLDING, PATHOGENESIS AND TRANSLATIONAL ASPECTS
Hall C
TRANSLATIONAL DRUG DISCOVERY AND EXPERIMENTAL MODELS 01
Hall F1
WHITE MATTER ALTERATIONS
Hall F2
14:50-15:50
FORUM 03: IMPROVING THE THERAPEUTIC POTENTIAL OF IMMUNOTHERAPIES IN AD – CAN NOVEL STRATEGIES OR NEXT GENERATION DRUGS HALT OR FURTHER DELAY DISEASE PROGRESSION?
Hall A
15:50-16:20
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
16:20-18:20
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
TAU MECHANISMS 01
Hall E
ANCESTRY AND GENETICS OF NEURODEGENERATION
Hall B
PD: I. DIAGNOSTIC MARKERS AND CLINICAL EVALUATION - II PATHOLOGICAL AND CLINICAL CORRELATES OF DEEP BRAIN STIMULATION
Hall C
TRANSLATIONAL DRUG DISCOVERY AND EXPERIMENTAL MODELS 02
Hall F1
MITOCHONDRIA AND NEURODEGENERATION, GLUCOCORTICOID VULNERABILITY
Hall F2
Thursday April 03, 2025
07:00-08:00
ON-DEMAND SYMPOSIA - ONLINE ONLY
On-Demand Oral Gallery
08:00-08:30
PLENARY LECTURE 04: DON PRICE MEMORIAL LECTURE
Hall A
08:40-10:40
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
CHOLINERGIC MECHANISMS IN AD AND PD (1)
Hall E
APOE: DISEASE MECHANISMS AND BIOLOGY
Hall B
AUTOPHAGY
Hall C
DISEASE AND RESILIENCE MECHANISMS: INFLAMMATION, ASTROGLIA, AND MORE
Hall F1
BIOMARKERS AND PATHOPHYSIOLOGY – WHAT IS THE IMPACT OF SEX?
Hall F2
10:40-11:10
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
11:10-12:50
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
12:50-13:50
EXHIBITION, POSTERS, LUNCH & INFORMAL NETWORKING WITH PROFESSORS
Exhibition
13:50-15:50
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
ABETA TARGETING THERAPIES IN AD 01
Hall E
LIPIDS IN AD & PD
Hall B
MECHANISMS (TDP-43, C9ORF72, TMEM106B) AND CLINICAL TRIALS IN FTD, ALS AND NEURODEGENERATION 01
Hall C
FLUID BIOMARKERS AND MULTIMODAL IMAGING FOR DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION
Hall F1
Α-SYNUCLEIN AGGREGATION. PROPAGATION AND NEUROTOXICITY
Hall F2
15:50-16:20
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
16:20-17:20
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
16:20-18:20
ARIA, MICROBLEEDS, CAA
Hall E
TAU MECHANISMS 02 & PSP
Hall B
PET AND MULTIMODAL IMAGING
Hall C
FLUID BIOMARKERS. AND IMAGING 01
Hall F1
CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS
Hall F2
17:30-18:30
FORUM 04: TRANSLATIONAL DRUG DEVELOPMENT IN AD (PHASE I-III) AND RELEVANCE FOR TREATMENT AND DISEASE MODIFICATION – WHAT COULD BE PROMISING STRATEGIES? SMALL MOLECULES FOR SYMPTOMATIC & DISEASE MODIFICATION?
Hall A
18:30-18:40
SHORT BREAK
Exhibition
18:40-20:05
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
Friday April 04, 2025
07:00-08:00
ON-DEMAND SYMPOSIA - ONLINE ONLY
On-Demand Oral Gallery
08:00-08:30
PLENARY LECTURE 05
Hall A
08:30-08:40
BREAK
Exhibition
08:40-10:40
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
CEREBROVASCULAR CHANGES, CAA, BBB 01
Hall E
PREVENTION AND THERAPEUTIC INTERVENTIONS IN AD
Hall B
PATHOLOGY OF NEURODEGENERATIVE DISEASES: UPDATES AND NEW FINDINGS
Hall C
BRAIN GUT INTERACTIONS, MICROBIOME
Hall F1
FLUID BIOMARKERS AND IMAGING 02
Hall F2
10:40-11:10
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
11:10-12:50
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
12:50-13:50
EXHIBITION, POSTERS, LUNCH & INFORMAL NETWORKING WITH PROFESSORS
Exhibition
13:50-15:50
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
FLUID AND DIGITAL BIOMARKERS AND IMAGING
Hall E
IMMUNITY AND INFLAMMATION IN NEURODEGENERATION
Hall B
LRKK2, ALPHA--SYNUCLEIN, PARKIN: DIAGNOSIS AND THERAPEUTIC TARGETS
Hall C
TAU AGGREGATION, PROPAGATION, DEPOSITION, AND PROTEIN MODIFICATIONS
Hall F1
RESILIENCE, LONGEVITY AND DRIVERS OF DISEASE PROGRESSION
Hall F2
15:50-16:20
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
16:20-17:20
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
16:20-18:20
MRI
Hall E
FLUID BIOMARKERS AND IMAGING 03
Hall B
DISEASE MECHANISMS, SYNAPSE PATHOLOGY & FUNCTION; INFLAMMATION: THERAPEUTIC TARGETS
Hall C
MICROGLIA
Hall F1
AD & PD: INSIGHTS FROM GENETICS
Hall F2
17:25-18:30
FORUM 05: NOVEL APPROACHES TO ACCELERATE DEVELOPMENT OF BIOMARKERS, IMAGING, AND THERAPY OF ALPHA-SYNUCLEIN, LRKK2, AND GBA PATHOLOGIES LINKED TO PD, LBD AND MSA
Hall A
18:30-18:40
SHORT BREAK
Exhibition
18:40-19:40
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
NEURODEGENERATIVE DISEASES: DIAGNOSIS & STAGING
Hall E
NEUROGENESIS, INFLAMMATION AND GLYMPHATIC FUNCTION
Hall B
CELL REPLACEMENT THERAPY & DIAGNOSTICS: CELLS, GLIA AND GRAFTS
Hall C
TAU PATHOLOGIES, PSP, LBD
Hall F1
COGNITIVE TRAJECTORIES, DIGITAL TWINS, POSTERIOR CORTICAL ATROPHY
Hall F2
Saturday April 05, 2025
07:00-08:00
ON-DEMAND SYMPOSIA - ONLINE ONLY
On-Demand Oral Gallery
08:00-08:30
PLENARY LECTURE 06
Hall A
08:30-08:40
BREAK
Exhibition
08:40-10:40
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
ABETA TARGETING THERAPIES IN AD 02
Hall E
BIOMARKERS IN CLINICAL USE ACROSS DEMENTIAS
Hall B
TRANSLATIONAL TREATMENT STRATEGIES AND NEW TARGETS
Hall C
CEREBROVASCULAR CHANGES, CAA, BBB 02
Hall F1
MECHANISMS (TDP-43, C9ORF72, TMEM106B) AND CLINICAL TRIALS IN FTD, ALS AND NEURODEGENERATION 02
Hall F2
10:40-11:10
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
11:10-13:10
INDUSTRY SYMPOSIUM (NO CME/CPD CREDIT)
Hall A
TAUOPATHIES: CHALLENGES IN TARGETING TAU
Hall E
SYMPOSIUM
Hall B
CHOLINERGIC MECHANISMS IN AD AND PD (2)
Hall C
AD & PD: TOWARDS NOVEL THERAPEUTIC INTERVENTION
Hall F1
FLUID BIOMARKERS AND IMAGING IN AD, PD, LBD 01
Hall F2
13:10-14:10
EXHIBITION, POSTERS, LUNCH & INFORMAL NETWORKING WITH PROFESSORS
Exhibition
14:10-15:10
FORUM 06: CHALLENGES AND OPPORTUNITIES FOR ANTI-TAU THERAPIES IN CLINICAL TRIALS – HOW CAN WE MAKE HOPES COME TRUE?
Hall A
14:10-16:10
PD AND LBD: ADVANCES IN DIAGNOSIS AND DRUG DEVELOPMENT
Hall E
SECRETASES AND APP PROCESSING
Hall B
ALPHA -- SYNUCLEINOPATHIES: MECHANISMS, PATHOPHYSIOLOGY AND MODELLING OF PROGRESSION 02
Hall C
EEG, DIAGNOSTCS AND OTHER ASSESSMENT TOOLS
Hall F1
FLUID BIOMARKERS AND IMAGING IN AD, PD, LBD 02
Hall F2
15:10-16:10
FORUM 07: THERAPY FOR AD, PD & LBD: NOVEL TRANSLATIONAL MODELS, NEW RECEPTOR- AND NEUROINFLAMMATION-BASED TARGETS – HOW CLOSE ARE WE TO SUCCESS?
Hall A
16:10-16:40
EXHIBITION, POSTERS AND COFFEE BREAK
Exhibition
16:40-17:40
FORUM 08: DRUG DEVELOPMENT & BIOMARKERS IN RARE CNS DISEASES (ALS, FTD): FROM BASICS TO APPROVAL – HOW TO DEFINE SUCCESS?
Hall A
16:40-18:55
ADVANCES IN AD DRUG DEVELOPMENT 02
Hall E
ADVANCES IN PD, LBD AND MSA DRUG DEVELOPMENT
Hall B
SYMPOSIUM
Hall A
SYMPOSIUM
Hall C
COVID-19 AND IMPACTS ON NEURODEGENERATION
Hall F1
FLUID BIOMARKERS AND IMAGING IN AD, PD, LBD 03
Hall F2
19:00-19:20
CLOSING CEREMONY
Hall A